Bal Pharma LimitedNSE: BALPHARMA

Press Release May 24 2021

· Issued by Bal Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-24-2021-12

Bal Pharma Limited has informed the Exchange regarding a press release dated May 24, 2021, titled "Launch of favipiravir formulation under the brand name BALflu , used in the treatment of COVID-19 virus.".

View Attachment

6ix hasn’t read this filing yet.

Bal Pharma Limited on 6ix

Later from Bal Pharma

All Bal Pharma news releases